bluebird bio (BLUE) Revenue & Revenue Breakdown
bluebird bio Revenue Highlights
Latest Revenue (Y)
$3.60M
Latest Revenue (Q)
$16.10M
Main Segment (Y)
Product
bluebird bio Revenue by Period
bluebird bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | $3.60M | -1.77% |
| 2021-12-31 | $3.66M | -98.54% |
| 2020-12-31 | $250.73M | 461.25% |
| 2019-12-31 | $44.67M | -18.15% |
| 2018-12-31 | $54.58M | 54.06% |
| 2017-12-31 | $35.43M | 475.58% |
| 2016-12-31 | $6.16M | -56.28% |
| 2015-12-31 | $14.08M | -44.62% |
| 2014-12-31 | $25.42M | 25.97% |
| 2013-12-31 | $20.18M | 5835.59% |
| 2012-12-31 | $340.00K | -61.45% |
| 2011-12-31 | $882.00K | - |
bluebird bio generated $3.60M in revenue during NA 2022, up -1.77% compared to the previous quarter, and up 10.15% compared to the same period a year ago.
bluebird bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $16.10M | -13.31% |
| 2024-03-31 | $18.57M | 137.08% |
| 2023-12-31 | $7.83M | -36.78% |
| 2023-09-30 | $12.39M | 79.85% |
| 2023-06-30 | $6.89M | 189.37% |
| 2023-03-31 | $2.38M | 3740.32% |
| 2022-12-31 | $62.00K | -12.68% |
| 2022-09-30 | $71.00K | -95.33% |
| 2022-06-30 | $1.52M | -21.90% |
| 2022-03-31 | $1.95M | 21.11% |
| 2021-12-31 | $1.61M | -92.92% |
| 2021-09-30 | $22.68M | 203.49% |
| 2021-06-30 | $7.47M | -41.60% |
| 2021-03-31 | $12.79M | 19.48% |
| 2020-12-31 | $10.71M | -44.44% |
| 2020-09-30 | $19.27M | -90.31% |
| 2020-06-30 | $198.89M | 809.71% |
| 2020-03-31 | $21.86M | 118.70% |
| 2019-12-31 | $10.00M | 12.20% |
| 2019-09-30 | $8.91M | -32.99% |
| 2019-06-30 | $13.30M | 6.62% |
| 2019-03-31 | $12.47M | -35.19% |
| 2018-12-31 | $19.24M | 66.92% |
| 2018-09-30 | $11.53M | 46.83% |
| 2018-06-30 | $7.85M | -50.80% |
| 2018-03-31 | $15.96M | 282.85% |
| 2017-12-31 | $4.17M | -45.95% |
| 2017-09-30 | $7.71M | -53.87% |
| 2017-06-30 | $16.72M | 144.67% |
| 2017-03-31 | $6.83M | 340.21% |
| 2016-12-31 | $1.55M | - |
| 2016-09-30 | $1.55M | - |
| 2016-06-30 | $1.55M | 3.54% |
| 2016-03-31 | $1.50M | 1.83% |
| 2015-12-31 | $1.47M | 11.18% |
| 2015-09-30 | $1.32M | -73.20% |
| 2015-06-30 | $4.94M | -22.13% |
| 2015-03-31 | $6.34M | -0.66% |
| 2014-12-31 | $6.39M | 0.33% |
| 2014-09-30 | $6.37M | 0.47% |
| 2014-06-30 | $6.33M | - |
| 2014-03-31 | $6.33M | - |
| 2013-12-31 | $6.33M | -0.78% |
| 2013-09-30 | $6.38M | 0.81% |
| 2013-06-30 | $6.33M | 462.02% |
| 2013-03-31 | $1.13M | 1225.88% |
| 2012-12-31 | $85.00K | - |
| 2012-09-30 | $85.00K | - |
| 2012-06-30 | $85.00K | - |
| 2012-03-31 | $85.00K | - |
bluebird bio generated $16.10M in revenue during Q2 2024, up -13.31% compared to the previous quarter, and up 676.23% compared to the same period a year ago.
bluebird bio Revenue Breakdown
bluebird bio Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Other Revenue | $858.00K | $812.00K | - | - | - |
| Product | $2.74M | $2.85M | - | - | - |
| Royalty And Other Revenue | - | - | $21.08M | - | - |
| Service | - | - | $114.06M | - | - |
| License And Royalty | - | - | - | $8.21M | $2.23M |
| Collaboration Arrangement | - | - | - | $36.47M | $1.60M |
| Royalty | - | - | - | - | $2.20M |
bluebird bio's latest annual revenue breakdown by segment (product or service), as of Dec 22: Product (76.15%), and Other Revenue (23.85%).
Quarterly Revenue by Product
| Product/Service | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Royalty And Other Revenue | $111.00K | $53.00K | $85.00K | $71.00K | $188.00K | $537.00K | $1.53M | $488.00K | $5.36M | $3.99M | $3.50M | $10.86M | - | - | - | - | - | - | - | - |
| Product | $12.28M | $6.84M | $2.30M | - | $1.33M | $1.41M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Service | - | - | - | - | - | - | $6.31M | $5.31M | $5.92M | $5.52M | $13.35M | $78.36M | $16.83M | - | - | - | - | - | - | - |
| License And Royalty | - | - | - | - | - | - | - | - | - | - | - | - | $2.73M | $2.84M | $2.33M | $1.74M | $1.29M | $861.00K | - | - |
| Collaboration Arrangement | - | - | - | - | - | - | - | - | - | - | - | - | - | $7.16M | $6.58M | $11.56M | $11.18M | - | - | - |
| Royalty | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $800.00K | $600.00K | $400.00K |
bluebird bio's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Product (99.10%), and Royalty And Other Revenue (0.90%).
bluebird bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SRPT | Sarepta Therapeutics | $1.24B | $413.46M |
| PTCT | PTC Therapeutics | $937.82M | $186.70M |
| KPTI | Karyopharm Therapeutics | $146.03M | $42.79M |
| TVTX | Travere Therapeutics | $145.24M | $62.90M |
| VIR | Vir Bio | $86.18M | $3.08M |
| YMAB | Y-mAbs Therapeutics | $84.82M | $22.80M |
| CVAC | CureVac | $52.70M | $12.37M |
| KRYS | Krystal Biotech | $50.70M | $70.28M |
| MRSN | Mersana Therapeutics | $36.85M | $2.29M |
| AGIO | Agios Pharmaceuticals | $26.82M | $8.96M |
| BLUE | bluebird bio | $3.60M | $16.10M |
| VKTX | Viking Therapeutics | - | - |
| MDGL | Madrigal Pharmaceuticals | - | $62.17M |
| ZNTL | Zentalis Pharmaceuticals | - | - |
| HEPA | Hepion Pharmaceuticals | - | - |
BLUE Revenue FAQ
What is bluebird bio’s yearly revenue?
bluebird bio's yearly revenue for 2022 was $3.6M, representing a decrease of -1.77% compared to 2021. The company's yearly revenue for 2021 was $3.66M, representing a decrease of -98.54% compared to 2020. BLUE's yearly revenue for 2020 was $250.73M, representing an increase of 461.25% compared to 2019.
What is bluebird bio’s quarterly revenue?
bluebird bio's quarterly revenue for Q2 2024 was $16.1M, a -13.31% decrease from the previous quarter (Q1 2024), and a 133.69% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $18.57M, a 137.08% increase from the previous quarter (Q4 2023), and a 680.05% increase year-over-year (Q1 2023). BLUE's quarterly revenue for Q4 2023 was $7.83M, a -36.78% decrease from the previous quarter (Q3 2023), and a 12535.48% increase year-over-year (Q4 2022).
What is bluebird bio’s revenue growth rate?
bluebird bio's revenue growth rate for the last 3 years (2020-2022) was -98.57%, and for the last 5 years (2018-2022) was -93.41%.
What are bluebird bio’s revenue streams?
bluebird bio's revenue streams in c 22 are Other Revenue, and Product. Other Revenue generated $858K in revenue, accounting 23.85% of the company's total revenue, up 5.67% year-over-year. Product generated $2.74M in revenue, accounting 76.15% of the company's total revenue, down -3.89% year-over-year.
What is bluebird bio’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of bluebird bio was Product. This segment made a revenue of $2.74M, representing 76.15% of the company's total revenue.